BioCryst Pharmaceuticals (BCRX) Competitor Comparison
We are evaluating the key criteria listed to compare BioCryst Pharmaceuticals (BCRX) against its competitors in the Biotechnology industry.
Market Capitalization
115 / 368Gross Profits
99 / 278Total Revenue
37 / 300EBITDA
210 / 337Free Cashflow
283 / 352Quick Ratio
187 / 357Earnings per Share
95 / 359Dividend yield
0 / 6Total Cash
75 / 358Performance 3 years
138 / 368Performance 5 years
34 / 368Performance 10 years
125 / 368Linearity 3 years
56 / 368Linearity 5 years
233 / 368Linearity 10 years
39 / 368Total Rank
241 / 368Dividend Rank
62 / 368Valuation Rank
267 / 368Piotroski Rank
239 / 368Muliplier Rank
293 / 368Market Capitalization - BCRX ranking 115 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.